Advertisement
New Zealand markets close in 4 hours 32 minutes
  • NZX 50

    11,687.98
    +5.59 (+0.05%)
     
  • NZD/USD

    0.6114
    -0.0007 (-0.12%)
     
  • NZD/EUR

    0.5713
    -0.0004 (-0.07%)
     
  • ALL ORDS

    8,032.40
    -7.50 (-0.09%)
     
  • ASX 200

    7,788.00
    -8.00 (-0.10%)
     
  • OIL

    80.36
    -0.37 (-0.46%)
     
  • GOLD

    2,331.40
    +0.20 (+0.01%)
     
  • NASDAQ

    19,700.43
    -51.87 (-0.26%)
     
  • FTSE

    8,237.72
    -34.74 (-0.42%)
     
  • Dow Jones

    39,150.33
    +15.53 (+0.04%)
     
  • DAX

    18,163.52
    -90.68 (-0.50%)
     
  • Hang Seng

    18,028.52
    -306.78 (-1.67%)
     
  • NIKKEI 225

    38,498.74
    -97.73 (-0.25%)
     
  • NZD/JPY

    97.7030
    -0.0720 (-0.07%)
     

Align Technology Full Year 2022 Earnings: EPS Misses Expectations

Align Technology (NASDAQ:ALGN) Full Year 2022 Results

Key Financial Results

  • Revenue: US$3.73b (down 5.5% from FY 2021).

  • Net income: US$361.6m (down 53% from FY 2021).

  • Profit margin: 9.7% (down from 20% in FY 2021). The decrease in margin was primarily driven by higher expenses.

  • EPS: US$4.62 (down from US$9.78 in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Align Technology EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%.

Looking ahead, revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.

ADVERTISEMENT

Performance of the American Medical Equipment industry.

The company's shares are up 27% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Align Technology, and understanding it should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here